{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:13:30Z","timestamp":1791220410309,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ahj.2008.05.013","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T04:31:54Z","timestamp":1216701114000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Angiotensin inhibition in renovascular disease: A population-based cohort study"],"prefix":"10.1016","volume":"156","author":[{"given":"Daniel G.","family":"Hackam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh L.","family":"Duong-Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon W.","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.05.013_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1067\/mva.2002.127351","article-title":"Prevalence of renovascular disease in the elderly: a population-based study","volume":"36","author":"Hansen","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ahj.2008.05.013_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCULATIONAHA.106.637751","article-title":"Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001","volume":"115","author":"Guo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.05.013_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jvs.2004.07.029","article-title":"Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001","volume":"40","author":"Knipp","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ahj.2008.05.013_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/ajkd.2001.24521","article-title":"Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States","volume":"37","author":"Fatica","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2008.05.013_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","article-title":"Atherosclerotic renovascular disease in United\u00a0States patients aged 67 years or older: risk factors, revascularization, and prognosis","volume":"68","author":"Kalra","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.05.013_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/hrt.2003.019505","article-title":"Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death","volume":"91","author":"Main","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2008.05.013_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14656566.3.4.411","article-title":"Treatment options for renovascular hypertension","volume":"3","author":"Spence","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ahj.2008.05.013_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1291\/hypres.27.339","article-title":"Angiotensin-converting enzyme inhibitor usage in patients with incidental atherosclerotic renal artery stenosis","volume":"27","author":"Yang","year":"2004","journal-title":"Hypertension Research-Clinical & Experimental"},{"key":"10.1016\/j.ahj.2008.05.013_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.107.097345","article-title":"The role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension","volume":"50","author":"Hackam","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2008.05.013_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/bmj.316.7149.1921","article-title":"Taking precautions with ACE inhibitors. A\u00a0theoretical risk exists in patients with unilateral renal artery stenosis","volume":"316","author":"Kumar","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2008.05.013_bib11","first-page":"CR462","article-title":"Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience","volume":"11","author":"Onuigbo","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ahj.2008.05.013_bib12","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators","volume":"12","year":"1996","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2008.05.013_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011131130922","article-title":"The EUROPA Trial: design, baseline demography and status of the substudies","volume":"15","author":"Gomma","year":"2001","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.ahj.2008.05.013_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9149(98)00488-3","article-title":"Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design)","volume":"82","author":"Pfeffer","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.05.013_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ahj.2008.05.013_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib17","first-page":"67","article-title":"Coding accuracy of administrative drug\u00a0claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2008.05.013_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mhj.2002.123839","article-title":"A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario","volume":"144","author":"Austin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.05.013_bib19","first-page":"477","article-title":"Validation of administrative databases using a registry data source: implications for research on quality of\u00a0stroke care","volume":"36","author":"Lindsay","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2008.05.013_bib20","series-title":"Cardiovascular health and services in Ontario: an ICES Atlas","article-title":"Technical methods\u2014Appendix 1","year":"1999"},{"key":"10.1016\/j.ahj.2008.05.013_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00005650-200502000-00012","article-title":"Comparison of coding of heart failure and\u00a0comorbidities in administrative and clinical data for use in outcomes research","volume":"43","author":"Lee","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2008.05.013_bib22","series-title":"Canadian Institute for Health Information Discharge Abstract Database: a validation study","author":"Juurlink","year":"2006"},{"key":"10.1016\/j.ahj.2008.05.013_bib23","series-title":"Achieving data quality in a statistical agency: a methodological perspective.","article-title":"The data quality study of the Canadian discharge abstract database.","author":"Richards","year":"2001"},{"key":"10.1016\/j.ahj.2008.05.013_bib24","series-title":"Data quality of the discharge abstract database following the first-year implementation of ICD-10-CA\/CCI: final report","year":"2004"},{"key":"10.1016\/j.ahj.2008.05.013_bib25","first-page":"351","article-title":"Towards improved coding of acute myocardial infarction in hospital discharge abstracts: a pilot project","volume":"13","author":"Cox","year":"1997","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2008.05.013_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.CIR.0000080290.39027.48","article-title":"Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists","volume":"108","author":"Jong","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.05.013_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM200102083440607","article-title":"Renal artery stenosis","volume":"344","author":"Safian","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinte.165.2.207","article-title":"Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study","volume":"165","author":"Edwards","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib29","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2005080827","article-title":"Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease","volume":"17","author":"Mui","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2008.05.013_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/153857440403800103","article-title":"Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study","volume":"38","author":"Edwards","year":"2004","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.ahj.2008.05.013_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1291\/hypres.25.537","article-title":"Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction","volume":"25","author":"Uzu","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ahj.2008.05.013_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2168.2002.02144.x","article-title":"Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease","volume":"89","author":"Pillay","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.ahj.2008.05.013_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.V131149","article-title":"Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion","volume":"13","author":"Cheung","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2008.05.013_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1046\/j.1523-1755.2001.00953.x","article-title":"Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography","volume":"60","author":"Conlon","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.05.013_bib35","first-page":"1037","article-title":"Factors affecting long-term survival following renal artery stenting","volume":"69","author":"Bates","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2008.05.013_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ahj.2008.05.013_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.resuscitation.2005.11.002","article-title":"Potassium disorders\u2014clinical spectrum and emergency management","volume":"70","author":"Alfonzo","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.ahj.2008.05.013_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.1992.tb00622.x","article-title":"Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible","volume":"232","author":"Devoy","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-2-1","article-title":"Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis","volume":"2","author":"Johansen","year":"2001","journal-title":"BMC Nephrology"},{"key":"10.1016\/j.ahj.2008.05.013_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0167-5273(95)02541-3","article-title":"ACE inhibitors and unilateral renal artery stenosis\u2014what price?","volume":"53","author":"Kothari","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2008.05.013_bib41","first-page":"360","article-title":"Progressive reversible kidney insufficiency after blood pressure reduction with captopril","volume":"22","author":"Kindler","year":"1981","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.ahj.2008.05.013_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.2.6190.612-c","article-title":"Reversible renal failure during treatment with captopril","volume":"2","author":"Collste","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.ahj.2008.05.013_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2005.09.011","article-title":"Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial","volume":"152","author":"Cooper","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.05.013_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0272-6386(99)70218-0","article-title":"Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis","volume":"33","author":"Tullis","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2008.05.013_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(85)90075-0","article-title":"Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension","volume":"79","author":"Franklin","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib46","first-page":"109","article-title":"Enalapril (MK421) in the treatment of hypertension with renal artery stenosis","volume":"1","author":"Hodsman","year":"1983","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ahj.2008.05.013_bib47","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1093\/ajh\/4.1.42S","article-title":"Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril","volume":"4","author":"Ogihara","year":"1991","journal-title":"Am J Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2008.05.013_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003495-198500301-00009","article-title":"Enalapril versus triple-drug therapy in the treatment of renovascular hypertension","volume":"30","author":"Reams","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2008.05.013_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF01728350","article-title":"The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension","volume":"60","author":"Schwietzer","year":"1982","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.ahj.2008.05.013_bib50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1503\/cmaj.050873","article-title":"Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies","volume":"174","author":"Papanikolaou","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.ahj.2008.05.013_bib51","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.05.013_bib52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bmj.38237.585000.7C","article-title":"Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review","volume":"329","author":"Strippoli","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2008.05.013_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1464-5491.2004.01122.x","article-title":"Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials","volume":"21","author":"Siebenhofer","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.ahj.2008.05.013_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0167-5273(89)90075-2","article-title":"High-risk patients treated with enalapril maleate: safety considerations","volume":"22","author":"Rucinska","year":"1989","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2008.05.013_bib56","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1523-1755.1998.00840.x","article-title":"Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease","volume":"53","author":"van de Ven","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2008.05.013_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(84)92149-4","article-title":"Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure","volume":"1","author":"Jackson","year":"1984","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308003852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308003852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:36:16Z","timestamp":1757568976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0002870308003852"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.05.013","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin inhibition in renovascular disease: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}